Marcus R. Kelly

Discovery and Targeting of a Cryptic Human Proteome

First-in-class therapeutics require first-in-class biology. Yet despite decades of genomic and proteomic cataloging, vast regions of the human transcriptome remain dark and their encoded proteins invisible. Here we present RyboCypher™, an integrated RNA-sequencing and AI-assisted proteogenomics platform that systematic...